Table 3 Multivariate analysis of clinical parameters and TILs for cervical cancer survival after NAC
PFS | OS | |||||
|---|---|---|---|---|---|---|
HR | 95% CI | P | HR | 95% CI | P | |
OR(OR vs. Non-OR) | 0.299 | 0.039–2.298 | 0.246 | 0.412 | 0.065–3.216 | 0.967 |
Clinical response (Yes vs. No) | 0.514 | 0.236–1.120 | 0.094 | 0.556 | 0.204–1.513 | 0.250 |
FIGO stage (Ib2 vs. IIa) | 1.560 | 0.686–3.551 | 0.289 | 2.212 | 0.808–6.508 | 0.122 |
Intratumoral CD8/Peritumoral FOXP3 after NACT | 0.297 | 0.109–0.810 | 0.018 | 0.078 | 0.010–0.598 | 0.014 |